JAK inhibitors in toxic epidermal necrolysis a new frontier in therapeutics.

Ann Med Surg (Lond) · 2026 · PMC12889396 · PMID 41675799

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

quite significantno p-value reported

This case is clinically quite significant because checkpoint inhibitor–induced TEN is becoming more common in oncology and has shown poorer outcomes with conventional therapeutic regimens.

also in 5,695 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.